Ignite Creation Date:
2025-12-26 @ 11:46 AM
Ignite Modification Date:
2025-12-26 @ 11:46 AM
Study NCT ID:
NCT06488716
Status:
TERMINATED
Last Update Posted:
2025-12-24
First Post:
2024-06-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-16
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-11-05
Completion Date Type:
ACTUAL
First Submit Date:
2024-06-20
First Submit QC Date:
None
Study First Post Date:
2024-07-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-17
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL